EMEA Medical Affairs Director, Evidence Strategy

Location: High Wycombe, Buckinghamshire, United Kingdom. The role is EMEA-based with up to 10% travel.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. This role leads the EMEA strategic evidence generation process across the lifecycle in the Janssen pipeline to enable rapid market access and differentiation versus competitor medicines.

Job Description

The EMEA Medical Affairs Director, Evidence Strategy is responsible for evolving and leading our EMEA evidence strategy across the Medical and Access domains. You will oversee a best-in-class end-to-end evidence generation strategy for EMEA, shaping decisions early in the product lifecycle and extending into mature life cycle stages.

Key Responsibilities

• Oversee best-in-class EMEA cross-TA evidence generation strategy.
• Establish a clear cross-TA process and operating model for:
• Evidence Generation short- to long-term plans
• EMEA Integrated Evidence Generation and Dissemination Plan

• Lead regional IEGP process for the EMEA region:
• Train IBVT and CVT teams on responsibilities and deliverables
• Organize and chair IEGP strategy (Q1) and IEGP tactics (Q2) reviews
• Establish prioritization for ESO EG investments
• Present consolidated plans and seek endorsement from leadership bodies (ESLT, ELT)

• Coordinate EMEA contribution to WW IEGP process:
• Align deliverables of EMEA and WW IEGP
• Review and optimize impact of WW IEGP for EMEA

• Collaborate with VP MAF and VP HEMAR to finalize the above.
• Oversee communication and roll-out of EMEA plans with key stakeholders.
• Identify and collate with stakeholders a core set of evidence deliverables and timelines that create value for EMEA.
• Incorporate competitive insights cross-TA via CI tools (Insight Miner) with CDS.
• Design and track medical and business impact of EMEA IEGP.
• Establish collaboration model with EMEA HEMAR and MAF TA teams with clear roles and responsibilities.
• Strengthen engagement with key countries to ensure input.
• Identify critical country priorities and facilitate early engagement between major EMEA markets and global decision-makers.
• Identify opportunities to strengthen EMEA input into core company processes (e.g., early CDP shaping, TPP development, regulatory filings).
• Continuously assess needs for new organizational capabilities or resources to support cross-TA evidence strategy.
• Contribute as needed to company processes such as long-range financial planning.

Essential Knowledge & Skills

• Extensive pharmaceutical background with a regional mindset; ability to assimilate complex science and data quickly. A higher scientific degree is preferred (e.g., PhD or MD).
• Behaviours aligned to the Johnson & Johnson Global Leadership Profile: integrity, collaboration, sense of urgency, results orientation, and people development.
• Up to 10% travel.
• Fluency in English required; additional EMEA languages are an advantage.

Experience

• Minimum of 8 years of progressive Medical Affairs experience with a track record of cross-functional leadership.
• Experience with R&D programs and development of commercial and evidence generation strategy.
• 5+ years on teams generating Evidence Generation plans.
• 5+ years on teams planning and executing Medical Education plans.

The role is based in the EMEA and may require extensive travel. The role holder should be based in their country of residence with access to local JJIM offices for hosting and travel.

Please note that this role is available across multiple countries and may be posted under different requisition numbers to comply with local requirements. Focus on the country(s) that align with your preferred location:

• UK: R-032723
• Switzerland: R-032718
• All other EMEA locations: R-032431

Seniority level

• Not Applicable

Employment type

• Full-time

Job function

• Health Care Provider
• Industries: Pharmaceutical Manufacturing

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.